GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $212M (100.0% shares, 0.0% debt)

Holdings (26)

IONS IONIS PHARMACEUTICALS INC 8.3%
Value $17.66M Shares 505,007 Est. Cost $39.21 Unrealized -4.7%
CYTK CYTOKINETICS INC 8.0%
Value $16.93M Shares 360,000 Est. Cost $51.77 Unrealized +0.3%
KALV KALVISTA PHARMACEUTICALS INC 7.1%
Value $15.14M Shares 1,787,003 Est. Cost $11.31 Unrealized -8.4%
VRDN VIRIDIAN THERAPEUTICS INC 6.8%
Value $14.38M Shares 750,000 Est. Cost $18.37 Unrealized +18.3%
PLRX PLIANT THERAPEUTICS INC 6.5%
Value $13.89M Shares 1,055,000 Est. Cost $16.18 Unrealized -15.6%
ABVX ABIVAX SA 5.7%
Value $12.07M Shares 1,648,523 Est. Cost $12.06 Unrealized
DYNAVAX TECHNOLOGIES CORP 5.2%
Value $10.98M Shares 860,000 Est. Cost $11.86 Unrealized
NGNE NEUROGENE INC 4.8%
Value $10.12M Shares 442,761 Est. Cost $14.51 Unrealized +156.4%
EOLS EVOLUS INC 4.7%
Value $9.887M Shares 895,524 Est. Cost $9.65 Unrealized +45.7%
XENE XENON PHARMACEUTICALS INC 4.5%
Value $9.615M Shares 245,272 Est. Cost $41.35 Unrealized 0.0%
UNICYCIVE THERAPEUTICS INC 4.1%
Value $8.72M Shares 10,980,000 Est. Cost $0.49 Unrealized
ZURA ZURA BIO LTD 3.7%
Value $7.925M Shares 3,170,194 Est. Cost $6.43 Unrealized -44.6%
AUTL AUTOLUS THERAPEUTICS PLC 3.3%
Value $7.072M Shares 3,009,392 Est. Cost $4.32 Unrealized
JSPR JASPER THERAPEUTICS INC 3.2%
Value $6.892M Shares 322,380 Est. Cost $17.76 Unrealized +17.2%
MERUS N V 3.1%
Value $6.648M Shares 158,092 Est. Cost $52.47 Unrealized
DNTH DIANTHUS THERAPEUTICS INC 2.8%
Value $5.995M Shares 275,000 Est. Cost $22.14 Unrealized +16.1%
BBOT HELIX ACQUISITION CORP II 2.5%
Value $5.25M Shares 500,000 Est. Cost $10.35 Unrealized +1.5%
UPB UPSTREAM BIO INC 2.3%
Value $4.932M Shares 300,000 Est. Cost $22.33 Unrealized 0.0%
CNTX CONTEXT THERAPEUTICS INC 2.3%
Value $4.918M Shares 4,683,711 Est. Cost $1.72 Unrealized +0.4%
VYGR VOYAGER THERAPEUTICS INC 2.2%
Value $4.688M Shares 826,751 Est. Cost $7.91 Unrealized
ORKA ORUKA THERAPEUTICS INC 2.1%
Value $4.436M Shares 228,803 Est. Cost $34.79 Unrealized -29.9%
MREO MEREO BIOPHARMA GROUP PLC 1.9%
Value $4.025M Shares 1,150,000 Est. Cost $3.50 Unrealized
RZLT REZOLUTE INC 1.4%
Value $3.047M Shares 621,894 Est. Cost $5.04 Unrealized 0.0%
PROMIS NEUROSCIENCES INC 1.2%
Value $2.507M Shares 2,645,128 Est. Cost $1.25 Unrealized
OPTINOSE INC 1.2%
Value $2.473M Shares 370,269 Est. Cost $6.68 Unrealized
URGN UROGEN PHARMA LTD 0.9%
Value $2.001M Shares 187,843 Est. Cost $15.87 Unrealized -24.6%